Alan F. Holmer, Director at Corbus Pharmaceuticals Holdings, Inc. (CRBP), bought 1,000 shares at $7.49 ($7K) on 2016-11-22, disclosed to the SEC on 2016-11-22.
Open-market purchase of $7k CRBP by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |